Nanjing Leads Biolabs Co., Ltd. Class H (9887) Stock Statistics & Valuation Metrics

Nanjing Leads Biolabs Co., Ltd. Class H has a market cap or net worth of HKD 7.16B. The enterprise value is HKD 8.68B.

Market Cap

HKD 7.16B

Enterprise Value

HKD 8.68B

Nanjing Leads Biolabs Co., Ltd. Class H has 197,670,290 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

197,670,290

Owned by Insiders

―

Owned by Institutions

0.43%

Nanjing Leads Biolabs Co., Ltd. Class H’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -14.00%.

Return on Equity (ROE)

-0.19

Return on Assets (ROA)

-0.13

Return on Invested Capital (ROIC)

-14.00%

Return on Capital Employed (ROCE)

-0.17

Revenue Per Employee

808.21K

Profits Per Employee

-963.98K

Employee Count

244

Asset Turnover

0.11

Inventory Turnover

0.00

The current PE Ratio of Nanjing Leads Biolabs Co., Ltd. Class H is -22.04. Nanjing Leads Biolabs Co., Ltd. Class H’s PEG ratio is 0.19.

PE Ratio

-22.04

PS Ratio

25.70

PB Ratio

6.45

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

0.19

In the last 12 months, Nanjing Leads Biolabs Co., Ltd. Class H had revenue of 197.20M and earned -235.21M in profits. Earnings per share was -1.35.

Revenue

197.20M

Gross Profit

197.20M

Operating Income

-216.42M

Pretax Income

-217.94M

Net Income

-235.21M

EBITDA

-195.21M

Earnings Per Share (EPS)

-1.35

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

Nanjing Leads Biolabs Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

0.00%

Earnings Yield

-4.52%

Beta

1.03

52-Week Price Change

-36.84%

50-Day Moving Average

53.82

200-Day Moving Average

62.72

Relative Strength Index (RSI)

28.74

Average Volume (3m)

1.71M

Nanjing Leads Biolabs Co., Ltd. Class H upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date

Aug 31, 2026

Next Earnings Date

―

Ex-Dividend Date

―

Nanjing Leads Biolabs Co., Ltd. Class H as a current ratio of 3.37, with Debt / Equity ratio of 22.16%

Current Ratio

3.37

Quick Ratio

3.25

Debt to Market Cap

0.03

Net Debt to EBITDA

4.82

Interest Coverage Ratio

-30.91

In the past 12 months, Nanjing Leads Biolabs Co., Ltd. Class H has paid 17.27M in taxes.

Income Tax

17.27M

Effective Tax Rate

-0.08

Nanjing Leads Biolabs Co., Ltd. Class H EV to EBITDA ratio is -26.10, with an EV/FCF ratio of 0.00.

EV to Sales

23.60

EV to EBITDA

-26.10

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

Nanjing Leads Biolabs Co., Ltd. Class H has HKD 1.24B in cash and marketable securities with HKD 373.39M in debt, giving a net cash position of HKD 868.66M billion.

Cash & Marketable Securities

HKD 1.24B

Total Debt

HKD 373.39M

Net Cash

HKD 868.66M

Net Cash Per Share

HKD 4.39

Tangible Book Value Per Share

HKD 4.71

Gross margin is 100.00%, with operating margin of -97.68%, and net profit margin of -117.34%.

Gross Margin

100.00%

Operating Margin

-97.68%

Pretax Margin

-108.61%

Net Profit Margin

-117.34%

EBITDA Margin

-90.43%

EBIT Margin

-97.68%

The average price target for Nanjing Leads Biolabs Co., Ltd. Class H is HKD 96.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

HKD 96.43

Price Target Upside

167.87% Upside

Analyst Consensus

Strong Buy

Analyst Count

4

Revenue Growth Forecast

―

EPS Growth Forecast

6.66%

Smart Score

6

AI Score

42